Jan 18, 2018 7:05am EST Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development
Dec 07, 2017 7:05am EST Immunovaccine and UConn Health Extend Collaboration to Support Advancement of Patient-Specific Immunotherapies to the Clinic
Dec 05, 2017 7:05am EST Immunovaccine Announces Positive Clinical Data from Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer
Dec 04, 2017 5:05pm EST Immunovaccine to Hold Webcast and Conference Call to Discuss Clinical Data From Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer
Nov 21, 2017 7:05am EST Immunovaccine and Leidos Expand Collaboration to Develop Malaria Vaccines Formulated in DepoVax™
Nov 13, 2017 7:05am EST Society for Immunotherapy of Cancer (SITC) Recognizes Immunovaccine Researchers with Journal for ImmunoTherapy of Cancer (JITC) “Best Basic Science Paper Award”
Nov 08, 2017 7:05am EST Immunovaccine Announces Regulatory Clearance for Phase 2 Clinical Trial Evaluating DPX-Survivac in Combination with Merck’s Checkpoint Inhibitor Pembrolizumab in DLBCL